An Investigator-initiated, Explorative Trial Evaluating the Effect of SAT-008 in Healthy Adults

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 8, 2020

Primary Completion Date

January 25, 2021

Study Completion Date

January 25, 2021

Conditions

Allergy and Immunology

Interventions

DEVICE

SAT-008

SAT-008 is a digital device containing several types of activities related to the immune function of adults.

Trial Locations (1)

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors

collaborator

Korea University Guro Hospital

OTHER

collaborator

S-Alpha Therapeutics, Inc.

INDUSTRY

lead

Seoul National University Bundang Hospital

OTHER

NCT04916145 - An Investigator-initiated, Explorative Trial Evaluating the Effect of SAT-008 in Healthy Adults | Biotech Hunter | Biotech Hunter